Every material Form 8-K Scilex Holding Co has filed with the SEC since July 22, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Scilex Holding Company amended a promissory note under which it extended an uncommitted revolving credit line to Vivasor, Inc., raising the maximum principal from $20 million to $30 million. The filing states that the Board and the Audit Committee approved the amendment, and that Vivasor is led by Scilex's CEO, Dr. Henry Ji, which makes it a related-party transaction shareholders can assess.
Amendment dated September 25, 2026 raised the maximum aggregate principal of the revolving line of credit from $20,000,000 to $30,000,000.
The original Promissory Note with Vivasor, Inc. was entered into on August 8, 2026; the amendment changed no other terms.
Dr. Henry Ji, Scilex's Chief Executive Officer, President and Chairperson, also serves as Chief Executive Officer of Vivasor.
The Board and the Audit Committee approved the amendment; a copy is filed as Exhibit 10.1.
Scilex Holding Company agreed on August 8, 2026 to set up an uncommitted revolving credit line of up to $20,000,000 in favor of Vivasor, Inc., a related party whose CEO is Scilex CEO Dr. Henry Ji. The company has no obligation to fund any drawdown, and each advance is at its sole discretion, so the line creates a possible future cash or stock outflow rather than an immediate one.
Maximum aggregate principal of up to $20,000,000 with a 120-month maturity from August 8, 2026
Interest at 5% per annum, accruing from each funded drawdown; Vivasor may prepay without penalty
Company may fund drawdowns in cash, freely tradable Scilex securities, or Datavault AI, Inc. common stock it holds, or a combination
Dr. Henry Ji is Scilex's CEO, President and Chairperson and also CEO of Vivasor; the Board and Audit Committee approved the note
Scilex Holding Company agreed on July 18, 2026 to sell Vivasor Holding Company shares of Vivasor preferred stock it had acquired in January 2026, for an aggregate price of $11,999,762.28. Payment is scheduled in tranches through June 30, 2027, and Vivasor may pay in cash, in shares of Datavault AI common stock, or a combination. The buyer is led by Scilex CEO Dr. Henry Ji, who is also Vivasor's CEO, a related-party arrangement shareholders may want to weigh.
Agreement dated July 18, 2026; Scilex sells 6,101,468 Series A-1 and 355,919 Series A-2 Vivasor preferred shares
Aggregate purchase price of $11,999,762.28, with $999,980.97 due July 18, 2026 and $4,999,901.10 due on or before September 30, 2026
Remaining installments of $1,999,960.07 each fall due by December 31, 2026, March 31, 2027 and June 30, 2027
Dr. Henry Ji serves as Scilex CEO, President and Chairperson and as CEO of Vivasor
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Scilex Holding Co filing is on SEC EDGAR ↗. 8-K briefs of other companies →